Gynaecological care of lesbian, bisexual, trans and non-binary people
- Routine care
Many LGBTI people avoid gynaecology after being judged or wrongly told they need no screening. Care by the organs present closes those gaps.
See it in 3D: Cervix · Body of uterus · Ovaries · Vagina · Mammary gland lobes · Breast fat
What it is
Lesbian, bisexual, trans and non-binary people and those with intersex variations need the same gynaecological care as anyone else, decided by the organs they have and the sex they have, not by their identity. Women who have sex with women still acquire HPV and other infections and need cervical screening. Trans men and non-binary people who have a cervix, uterus, ovaries or breast tissue need screening for those organs, and testosterone does not prevent pregnancy. Trans women do not have a cervix, even after vaginoplasty, but may need breast screening after years of oestrogen. Barriers are mostly in the service: assumptions, wrong names and forms built for one kind of patient.
What it looks for
- Cervical screening for anyone with a cervix, on the usual schedule, including women who have only had female partners and trans men on testosterone.
- HPV and other infections pass by skin-to-skin and genital contact, fingers and shared sex toys, not only by penile intercourse.
- Bacterial vaginosis is more common among women who have sex with women and often occurs in both partners.
- Testosterone is not contraception: a trans man with a uterus and ovaries can become pregnant, and testosterone is harmful to a fetus.
- Breast or chest screening by tissue present: trans men without chest surgery are screened as other people with breasts; after chest reconstruction some tissue remains; trans women may be offered screening after several years of oestrogen, following local rules.
- Mental health and violence: minority stress raises depression, anxiety and substance use, and these patients face more violence; ask about safety.
How it is done
- Ask and use the person's name and pronouns; record them so every team member uses them.
- Take a history without assumptions: 'Who are your partners? What kind of sex do you have? Is pregnancy possible?'
- Make an organ inventory and note any gender-affirming hormones or surgery, and fertility plans.
- Explain each examination, ask consent at every step, offer a chaperone and a smaller speculum, and offer HPV self-sampling where available.
- Apply the usual screening by organ: cervix, breast or chest tissue, and pelvic organs if bleeding or pain appear.
- Prevention by behaviour: STI tests, HPV and hepatitis B vaccines, HIV pre-exposure prophylaxis if the risk is high, contraception if pregnancy is possible.
- Coordinate with the clinician managing gender-affirming hormones and with mental health support when needed.
Screening by organ, not identity
| Organ | Who may have it | What to do | Notes |
|---|---|---|---|
| Cervix | Cis women (all partners), trans men and non-binary people assigned female at birth | Usual cervical screening | Testosterone thins the epithelium: more inadequate smears; self-sampled HPV testing helps |
| Uterus and ovaries | As above, unless removed | Investigate abnormal bleeding; contraception if pregnancy is possible | Bleeding after amenorrhoea on testosterone needs evaluation |
| Breast or chest tissue | Cis women, trans men without (or with partial) chest surgery, trans women on oestrogen | Breast screening by tissue and programme rules | Chest reconstruction leaves some tissue: examine the chest |
| Neovagina | Trans women after vaginoplasty | No cervical screening; examine for granulation, stenosis and STIs | Usually lined with penile or scrotal skin, so there is no cervix |
| Prostate | Trans women and non-binary people assigned male at birth | As for others with a prostate | The prostate is not removed at vaginoplasty |
Common mistakes
- Avoidance chain: a woman is told she does not need screening because she has sex with women, or a trans man is misgendered at the desk → she or he stops coming → cervical cancer and STIs are found late.
- Testosterone and the pelvic examination: vaginal atrophy makes the speculum painful and cytology more often inadequate; a small speculum, lubricant, self-sampling or a short course of vaginal oestrogen where agreed can help.
- Testosterone usually stops periods; breakthrough bleeding on stable treatment needs the same thinking as abnormal bleeding in anyone with a uterus, including pregnancy and endometrial causes.
- Contraception for trans men: methods without oestrogen are usually preferred (copper or levonorgestrel intrauterine device, implant, progestogen injection); progestogen methods can also suppress periods.
- Oestrogen in trans women raises venous thromboembolism risk, more with smoking and older oral formulations; this matters before surgery.
- Do not examine more than the visit needs: curiosity about anatomy is not a clinical reason, and unnecessary examinations drive people away.
Next step / When to refer
- Book cervical screening for everyone with a cervix on the usual programme, and offer HPV self-sampling where available.
- Offer STI testing by practices and sites (genital, oral, anal), and HIV pre-exposure prophylaxis where the risk is high.
- Discuss contraception with anyone who can become pregnant, including trans men on testosterone.
- Investigate abnormal or new bleeding, pelvic pain and breast or chest lumps as for anyone with those organs.
- Refer to the clinician managing gender-affirming hormones, to fertility services before treatment that may affect fertility, and to mental health or violence support when needed.
Common traps
- Women who have sex only with women do not need cervical screening: HPV passes by genital and skin contact, fingers and toys, and many have had male partners.
- Testosterone works as contraception: ovulation can still happen, and testosterone can harm a fetus, so contraception is needed.
- A trans woman needs cervical screening after vaginoplasty: the neovagina has no cervix; she needs examination of the neovagina and prostate care instead.
- Chest reconstruction removes all breast tissue: some remains, so new chest lumps still need assessment.
- Asking about identity is enough to know the risks: identity does not tell you the organs present or the sex practised; ask about both.
Test yourself
Think of the answer, then tap the question to see it.
A 35-year-old woman who has only had female partners asks whether she needs cervical screening. What do you tell her?
Yes, on the usual schedule: HPV spreads by genital and skin contact, fingers and shared toys, so her risk is not zero.
A 24-year-old trans man on testosterone for two years has had no periods and asks whether he still needs contraception. What is the answer?
Yes, if he has sex that can cause pregnancy: testosterone does not reliably stop ovulation and is harmful to a fetus; non-oestrogen methods are usually preferred.
Does a trans woman who has had vaginoplasty need cervical screening?
No. The neovagina is made from penile or scrotal skin and has no cervix; she needs examination of the neovagina for problems and the usual prostate care.
Why are cervical samples more often inadequate in trans men on testosterone, and what helps?
Testosterone thins the cervical and vaginal epithelium; a small speculum, lubricant, HPV self-sampling or a short course of vaginal oestrogen where agreed can help.
Elsewhere in DurgiPedia
- Gender-affirming hormone therapy: principles and monitoring
- Gynecologic and obstetric history
- Gynecologic examination: speculum and bimanual exam
- Professional secrecy and confidentiality
- STI counselling: risk reduction, testing, partner notification and condom teaching
Connections
See it in 3D6
The structures of Durgical's 3D anatomy where it is found.
← All of obstetrics and gynaecology
Educational content; it does not replace assessment by a doctor or your institution's protocols, and it contains no doses. For heavy bleeding, a severe headache or blurred vision, a seizure, fever, strong abdominal pain or fewer baby movements, go to an emergency department at once.
Sources: Cultural Competence in the Care of LGBTQ Patients (StatPearls (NCBI Bookshelf), 2023); Gender Dysphoria (StatPearls (NCBI Bookshelf), 2026); Menstrual Suppression (StatPearls (NCBI Bookshelf), 2024); WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention (World Health Organization, 2021).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
